7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Fractures, Stress D015775 2 associated lipids
Osteosclerosis D010026 2 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Osteophyte D054850 2 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Pericardial Effusion D010490 2 associated lipids
Lymphocytosis D008218 2 associated lipids
Radicular Cyst D011842 2 associated lipids
Gingival Recession D005889 2 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Lotinun S et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. 2013 J. Clin. Invest. pmid:23321671
Dorotheou D et al. Tooth eruption: altered gene expression in the dental follicle of patients with cleidocranial dysplasia. 2013 Orthod Craniofac Res pmid:23311656
Curl L et al. A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation. 2012 Aust Orthod J pmid:23304971
Kadkhodazadeh M et al. Analysis of osteoprotegerin (OPG) gene polymorphism in Iranian patients with chronic periodontitis and peri-implantitis. A cross-sectional study. 2012 Eur J Oral Implantol pmid:23304691
Wada T [RANKL inhibition in bone metastases]. 2013 Nippon Yakurigaku Zasshi pmid:23302944
Wong KC et al. Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone. 2013 Br. J. Nutr. pmid:23302510
Feng Q et al. [Effect of sonicated extracts of Porphyromonas gingivalis on receptor activator of NF-κB ligand and osteoprotegerin expression in periodontal ligament cells]. 2012 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:23302383
Aoki A et al. Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes. 2013 Cardiovasc Diabetol pmid:23302066
Su SJ et al. Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line. 2013 Int J Food Sci Nutr pmid:23301724
Nehring P et al. Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex‑specific rs2073618 polymorphism as a risk factor for diabetic foot. 2013 Pol. Arch. Med. Wewn. pmid:23299915
Hoy J et al. Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy. 2013 J. Bone Miner. Res. pmid:23299909
dos Santos PL et al. Guided implant surgery: what is the influence of this new technique on bone cell viability? 2013 J. Oral Maxillofac. Surg. pmid:23298799
Eleftheriadis T et al. Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients. 2013 Int Urol Nephrol pmid:23296793
Steinmetz M et al. Atorvastatin-induced increase in progenitor cell levels is rather caused by enhanced receptor activator of NF-kappaB ligand (RANKL) cell proliferation than by bone marrow mobilization. 2013 J. Mol. Cell. Cardiol. pmid:23295770
Xi L et al. OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery. 2013 Cardiology pmid:23295350
Koide M et al. Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice. 2013 Endocrinology pmid:23291450
Eren MA et al. Association of parity with osteoprotegerin levels and atherosclerosis. 2013 Arch. Gynecol. Obstet. pmid:23287888
pmid:23279451
de Moraes M et al. Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts. 2013 J. Oral Pathol. Med. pmid:23278112
Levidou G et al. TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis. 2013 Pathology pmid:23277172
Engvall IL et al. Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction. 2013 Rheumatology (Oxford) pmid:23275387
Hyseni A et al. Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients. 2013 Thromb. Res. pmid:23273402
Flórez-Moreno GA et al. Time-related changes in salivary levels of the osteotropic factors sRANKL and OPG through orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23273364
Kuang B et al. Combined degenerative and regenerative remodeling responses of the mandibular condyle to experimentally induced disordered occlusion. 2013 Am J Orthod Dentofacial Orthop pmid:23273362
Hussien YM et al. Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. 2013 Mol. Biol. Rep. pmid:23271131
Dong W et al. [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:23268391
Matsuo K [Osteoimmunologic regulation of aging]. 2013 Clin Calcium pmid:23268303
Owen S et al. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. 2013 Anticancer Res. pmid:23267146
Brabnikova Maresova K et al. Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes. 2013 Calcif. Tissue Int. pmid:23247536
Gao L et al. Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. 2013 J. Immunol. pmid:23241890
Giganti MG et al. Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. 2012 Oct-Dec J. Biol. Regul. Homeost. Agents pmid:23241117
Yassuda DH et al. Magnesium incorporation into β-TCP reduced its in vivo resorption by decreasing parathormone production. 2013 J Biomed Mater Res A pmid:23239606
Li L et al. [Progress of osteogenic effect of strontium and its application in orthopaedics]. 2012 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:23230680
Liu T et al. [Correlation between local microenvironment leptin expression and avascular necrosis of the femoral head]. 2012 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:23230665
Peris P et al. Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. 2013 Mayo Clin. Proc. pmid:23228561
Aranha AM et al. Evidence supporting a protective role for th9 and th22 cytokines in human and experimental periapical lesions. 2013 J Endod pmid:23228262
Kanzaki H et al. Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells. 2013 Exp. Mol. Pathol. pmid:23219833
Kim SJ et al. Compressive stress induced the up-regulation of M-CSF, RANKL, TNF-α expression and the down-regulation of OPG expression in PDL cells via the integrin-FAK pathway. 2013 Arch. Oral Biol. pmid:23219295
Glintborg D et al. Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23211475
Rashtchizadeh N et al. Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. 2012 Ther Apher Dial pmid:23190522
Wang S and Liu YS [Advance on arterial calcification]. 2012 Sheng Li Ke Xue Jin Zhan pmid:23189619
Okamura H et al. Protein phosphatase 2A Cα is involved in osteoclastogenesis by regulating RANKL and OPG expression in osteoblasts. 2013 FEBS Lett. pmid:23183242
Dalcico R et al. Protective mechanisms of simvastatin in experimental periodontal disease. 2013 J. Periodontol. pmid:23181416
Bolzoni M et al. Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules. 2013 Exp. Hematol. pmid:23178378
Gutiérrez-Rojas I et al. Amylin exerts osteogenic actions with different efficacy depending on the diabetic status. 2013 Mol. Cell. Endocrinol. pmid:23178165
Kadkhodazadeh M et al. Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. 2013 Arch. Oral Biol. pmid:23177932
Romagnoli C et al. Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. 2013 FEBS J. pmid:23176170
Braun T et al. Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. 2013 J. Bone Miner. Res. pmid:23169443
Luo ZR and Xie QJ [Correlation between osteoprotegerin gene 209G/A, 245T/G and 1181G/C polymorphism and acute coronary syndromes in Han people of Fujian area]. 2012 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:23168201
Bilgin E et al. Markers of bone metastases in breast and lung cancers. 2012 Asian Pac. J. Cancer Prev. pmid:23167338
Heitzer E et al. IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. 2012 Nov-Dec Pain Physician pmid:23159968
Jia P et al. [The effect of ferric ion on the differentiation of osteoclast and bone resorption]. 2012 Zhonghua Yi Xue Za Zhi pmid:23158430
Nicu EA et al. RCT comparing implants with turned and anodically oxidized surfaces: a pilot study, a 3-year follow-up. 2012 J. Clin. Periodontol. pmid:23151294
Crotti TN et al. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints. 2012 Arthritis Res. Ther. pmid:23146195
Xue Y et al. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. 2012 PLoS ONE pmid:23144698
Silva HC et al. Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements. 2013 Bone pmid:23142805
Mogelvang R et al. Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP. 2013 Heart pmid:23135978
Guo L et al. Effects of erythropoietin on osteoblast proliferation and function. 2014 Clin. Exp. Med. pmid:23135151
Kim HS et al. The flavonoid glabridin attenuates 2-deoxy-D-ribose-induced oxidative damage and cellular dysfunction in MC3T3-E1 osteoblastic cells. 2013 Int. J. Mol. Med. pmid:23128413
Osorio A et al. Biochemical markers of vascular calcification in elderly hemodialysis patients. 2013 Mol. Cell. Biochem. pmid:23124853
Balani D et al. Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro. 2013 Arthritis Rheum. pmid:23124514
Montagnana M et al. The role of osteoprotegerin in cardiovascular disease. 2013 Ann. Med. pmid:23110639
MacNee W Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. 2013 Ann. Med. pmid:23110517
pmid:23104956
Ahmed HH et al. Potential role of leptin against glucocorticoid-induced secondary osteoporosis in adult female rats. 2012 Eur Rev Med Pharmacol Sci pmid:23104664
Zhang ZG et al. Therapeutic effect of aqueous extract from Ecliptae herba on bone metabolism of ovariectomized rats. 2013 Menopause pmid:23096243
Ryser MD et al. Osteoprotegerin in bone metastases: mathematical solution to the puzzle. 2012 PLoS Comput. Biol. pmid:23093918
Brandenburg V et al. Calcification inhibitors in vascular calciphylaxis associated with normal renal function. 2012 Thromb. Haemost. pmid:23092963
Kim IS et al. Human mesenchymal stromal cells are mechanosensitive to vibration stimuli. 2012 J. Dent. Res. pmid:23086742
Wang Y et al. The effect of adenovirus-mediated siRNA targeting BMPR-II on UHMWPE-induced osteoclast formation. 2013 Biomaterials pmid:23079666
Wang ST et al. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria. 2013 Clin. Nephrol. pmid:23073066
Wang D et al. Accelerated calvarial healing in mice lacking Toll-like receptor 4. 2012 PLoS ONE pmid:23071670
Xiang G et al. Change of plasma osteoprotegerin and its association with endothelial dysfunction before and after exercise in Hashimoto's thyroiditis with euthyroidism. 2012 Exp. Clin. Endocrinol. Diabetes pmid:23070830
Sottnik JL and Keller ET Understanding and targeting osteoclastic activity in prostate cancer bone metastases. 2013 Curr. Mol. Med. pmid:23061677
Nyrnes A et al. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study. 2012 Gend Med pmid:23046763
Udomsuk L et al. Impact of Pueraria candollei var. mirifica and its potent phytoestrogen miroestrol on expression of bone-specific genes in ovariectomized mice. 2012 Fitoterapia pmid:23041523
Tobón-Arroyave SI et al. Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. 2012 J. Clin. Periodontol. pmid:23039038
Taddei SR et al. Experimental model of tooth movement in mice: a standardized protocol for studying bone remodeling under compression and tensile strains. 2012 J Biomech pmid:23036306
Scott JP et al. Effect of recovery duration between two bouts of running on bone metabolism. 2013 Med Sci Sports Exerc pmid:23034642
Song TJ et al. Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients. 2012 Biomarkers pmid:23030274
Dey P et al. Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. 2012 Mol. Endocrinol. pmid:23028063
Taylan A et al. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. 2012 BMC Musculoskelet Disord pmid:23025387
Jansson AM et al. Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:23023373
Rieder P et al. TiNOx coatings increase human primary osteoblasts proliferation independently of the substrate: a short report. 2012 Biomed Mater Eng pmid:23023144
Bosselut N et al. Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy. 2013 Clin. Chim. Acta pmid:23022619
Thadani U Osteoprotegerin and ST segment myocardial infarction: a novel risk marker but not for routine use at present. 2012 Cardiology pmid:23018624
Martínez E et al. Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir. 2012 AIDS pmid:23018438
Giaginis C et al. Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis. 2012 Med. Sci. Monit. pmid:23018352
Rivadeneira F Hunting osteoporosis susceptibility genes: bigger is better but diverse is also welcome. 2013 Endocrine pmid:23001603
Ostrowska Z et al.  Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa. 2012 Postepy Hig Med Dosw (Online) pmid:23001207
Lazzerini PE et al. Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 2013 Joint Bone Spine pmid:22999910
Qiu S et al. [Design and activity verification of human parathyroid hormone (1-34) mutant protein]. 2012 Yao Xue Xue Bao pmid:22993856
Dieckmann M et al. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo. 2013 J. Bone Miner. Res. pmid:22991192
Li YL and Wang H [Serum osteoprotegerin level in children with nephrotic syndrome and the effect of glucocorticoid on it]. 2012 Zhongguo Dang Dai Er Ke Za Zhi pmid:22989431
Grant M et al. Induction of cytokines, MMP9, TIMPs, RANKL and OPG during orthodontic tooth movement. 2013 Eur J Orthod pmid:22987319
Yilmaz Y and Eren F Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis. 2012 Clin. Chim. Acta pmid:22985537
Pathan E et al. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. 2013 Ann. Rheum. Dis. pmid:22984171
Kadoglou NP et al. Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms. 2012 Regul. Pept. pmid:22982141
Ambroszkiewicz J et al. [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. 2012 Apr-Jun Med Wieku Rozwoj pmid:22971655
Tyagi AM et al. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. 2012 PLoS ONE pmid:22970248

Table of Content